title: NMR spectroscopy in beta cell engineering and islet transplantation.
abstract: Islet transplantation is a promising method for restoring normoglycemia and alleviating the long term complications of diabetes. Widespread application of islet transplantation is hindered by the limited supply of human islets and requires a large increase in the availability of suitable insulin secreting tissue as well as robust quality assessment methodologies that can ensure safety and in vivo efficacy. We explore the application of nuclear magnetic resonance (NMR) spectroscopy in two areas relevant to beta cell engineering and islet transplantation: (1) the effect of genetic alterations on glucose metabolism, and (2) quality assessment of islet preparations prior to transplantation. Results obtained utilizing a variety of NMR techniques demonstrate the following: (1) Transfection of Rat1 cells with the c-myc oncogene (which may be involved in cell proliferation and cell cycle regulation) and overexpression of Bcl-2 (which may protect cells from stresses such as hypoxia and exposure to cytokines) introduce a wide array of alterations in cellular biochemistry, including changes in anaerobic and oxidative glucose metabolism, as assessed by 13C and 31P NMR spectroscopy. (2) Overnight incubation of islets and beta cells in the bottom of centrifuge tubes filled with medium at room temperature, as is sometimes done in islet transportation, exposes them to severe oxygen limitations that may cause cell damage. Such exposure, leading to reversible or irreversible damage, can be observed with NMR-detectable markers using conventional 13C and 31P NMR spectroscopy of extracts. In addition, markers of irreversible damage (as well as markers of hypoxia) can be detected and quantified without cell extraction using high-resolution magic angle spinning 1H NMR spectroscopy. Finally, acute ischemia in a bed of perfused beta cells leads to completely reversible changes that can be followed in real time with 31P NMR spectroscopy.
authors.affiliation: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge 02139-4307, USA. kpapas@mit.edu
authors.forename: K K
authors.initials: KK
authors.lastname: Papas
authors.forename: C K
authors.initials: CK
authors.lastname: Colton
authors.forename: J S
authors.initials: JS
authors.lastname: Gounarides
authors.forename: E S
authors.initials: ES
authors.lastname: Roos
authors.forename: M A
authors.initials: MA
authors.lastname: Jarema
authors.forename: M J
authors.initials: MJ
authors.lastname: Shapiro
authors.forename: L L
authors.initials: LL
authors.lastname: Cheng
authors.forename: G W
authors.initials: GW
authors.lastname: Cline
authors.forename: G I
authors.initials: GI
authors.lastname: Shulman
authors.forename: H
authors.initials: H
authors.lastname: Wu
authors.forename: S
authors.initials: S
authors.lastname: Bonner-Weir
authors.forename: G C
authors.initials: GC
authors.lastname: Weir
mesh_terms: D000818:Animals; D002460:Cell Line; D019254:Genes, bcl-2; D016259:Genes, myc; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology* / Q000378:metabolism; D016381:Islets of Langerhans Transplantation; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D051381:Rats; D023822:Tissue Engineering
chemical_list: D005947:Glucose